HEADER TRANSFERASE 06-MAR-08 3CGX TITLE CRYSTAL STRUCTURE OF PUTATIVE NUCLEOTIDE-DIPHOSPHO-SUGAR TRANSFERASE TITLE 2 (YP_389115.1) FROM DESULFOVIBRIO DESULFURICANS G20 AT 1.90 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE NUCLEOTIDE-DIPHOSPHO-SUGAR TRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DESULFOVIBRIO DESULFURICANS SUBSP. SOURCE 3 DESULFURICANS STR.; SOURCE 4 ORGANISM_TAXID: 207559; SOURCE 5 STRAIN: G20; SOURCE 6 GENE: YP_389115.1, DDE_2624; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_389115.1, PUTATIVE NUCLEOTIDE-DIPHOSPHO-SUGAR TRANSFERASE, KEYWDS 2 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 3 PROTEIN STRUCTURE INITIATIVE, PSI-2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3CGX 1 REMARK SEQADV REVDAT 5 24-JUL-19 3CGX 1 REMARK LINK REVDAT 4 25-OCT-17 3CGX 1 REMARK REVDAT 3 13-JUL-11 3CGX 1 VERSN REVDAT 2 24-FEB-09 3CGX 1 VERSN REVDAT 1 18-MAR-08 3CGX 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE NUCLEOTIDE-DIPHOSPHO-SUGAR JRNL TITL 2 TRANSFERASE (YP_389115.1) FROM DESULFOVIBRIO DESULFURICANS JRNL TITL 3 G20 AT 1.90 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 21971 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1128 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1514 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.09 REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1809 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 199 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 25.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.27000 REMARK 3 B22 (A**2) : 0.32000 REMARK 3 B33 (A**2) : -0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.135 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.129 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.088 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.874 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1920 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1271 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2618 ; 1.553 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3098 ; 1.067 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 244 ; 4.756 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 91 ;38.582 ;24.725 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 306 ;12.279 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;21.673 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 277 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2213 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 401 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1191 ; 1.948 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 480 ; 0.556 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1910 ; 3.219 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 729 ; 5.152 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 708 ; 7.416 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 231 REMARK 3 ORIGIN FOR THE GROUP (A): 25.6860 27.9180 0.6990 REMARK 3 T TENSOR REMARK 3 T11: -0.0942 T22: -0.0472 REMARK 3 T33: -0.0740 T12: -0.0113 REMARK 3 T13: -0.0133 T23: -0.0077 REMARK 3 L TENSOR REMARK 3 L11: 1.2019 L22: 1.2680 REMARK 3 L33: 1.1011 L12: -0.3667 REMARK 3 L13: -0.4097 L23: 0.3460 REMARK 3 S TENSOR REMARK 3 S11: 0.0076 S12: -0.0519 S13: 0.0517 REMARK 3 S21: 0.0796 S22: -0.0109 S23: 0.0153 REMARK 3 S31: -0.0712 S32: 0.0475 S33: 0.0033 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. REMARK 3 4. IMIDAZOLE FROM PROTEIN EXPRESSION IS MODELED IN THIS STRUCTURE. REMARK 4 REMARK 4 3CGX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046762. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97908 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22017 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 28.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.570 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.950 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 20.0% GLYCEROL, 0.04M REMARK 280 KH2PO4, 16.0% PEG 8000, NO BUFFER, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.26000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.83500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.47000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.83500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.26000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.47000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 LEU A 232 REMARK 465 PRO A 233 REMARK 465 GLY A 234 REMARK 465 MSE A 235 REMARK 465 ALA A 236 REMARK 465 PRO A 237 REMARK 465 VAL A 238 REMARK 465 GLU A 239 REMARK 465 LYS A 240 REMARK 465 GLU A 241 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 17 CE NZ REMARK 470 ARG A 48 NE CZ NH1 NH2 REMARK 470 HIS A 50 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 148 CZ NH1 NH2 REMARK 470 ARG A 161 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 164 CG CD OE1 OE2 REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 ARG A 176 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 177 NE CZ NH1 NH2 REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 205 CG CD CE NZ REMARK 470 ASN A 206 CG OD1 ND2 REMARK 470 ARG A 210 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 231 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 117 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 51 146.66 -171.30 REMARK 500 ASN A 206 8.59 80.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 242 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 379240 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3CGX A 1 241 UNP Q30Y26 Q30Y26_DESDG 1 241 SEQADV 3CGX GLY A 0 UNP Q30Y26 EXPRESSION TAG SEQRES 1 A 242 GLY MSE SER GLU SER CYS ILE LEU PHE PHE VAL LYS TYR SEQRES 2 A 242 PRO GLU PRO GLY LYS VAL LYS THR ARG LEU GLY GLU VAL SEQRES 3 A 242 VAL GLY ASN ASP LYS ALA ALA MSE LEU TYR ARG HIS PHE SEQRES 4 A 242 VAL GLN ASP MSE LEU GLN GLY LEU ALA ARG LEU HIS ALA SEQRES 5 A 242 ASP LEU HIS ILE CYS TYR VAL PRO GLY ASP ALA ASP LEU SEQRES 6 A 242 PRO GLU LYS PHE LYS ALA TRP LEU GLY PRO GLN HIS MSE SEQRES 7 A 242 PHE ALA ALA GLN GLN GLY LEU ASP LEU GLY GLU ARG MSE SEQRES 8 A 242 LYS HIS ALA MSE GLN LYS ALA PHE ASP ASP GLY TYR ASP SEQRES 9 A 242 ARG VAL VAL LEU MSE GLY SER ASP ILE PRO ASP TYR PRO SEQRES 10 A 242 CYS GLU LEU VAL GLN LYS ALA LEU ASN ASP LEU GLN HIS SEQRES 11 A 242 TYR ASP ALA ALA ILE GLY PRO ALA PHE ASP GLY GLY TYR SEQRES 12 A 242 TYR LEU ILE GLY PHE ARG LYS ASP SER PHE CYS PRO ASP SEQRES 13 A 242 VAL PHE ASP GLY ILE ARG TRP GLY GLU ALA ASP VAL TYR SEQRES 14 A 242 GLN PRO THR VAL GLU LYS MSE ARG ARG ALA ARG LEU GLU SEQRES 15 A 242 VAL LEU GLN LEU PRO ASP TRP ASN ASP VAL ASP THR VAL SEQRES 16 A 242 TRP ASP LEU ASN VAL LEU TYR ARG THR ASN LYS ASN SER SEQRES 17 A 242 SER PHE ARG ARG SER SER THR TYR ALA LEU LEU ARG GLU SEQRES 18 A 242 ASN ASP ALA LEU ILE ARG GLN TYR ASP ILE ASP LEU PRO SEQRES 19 A 242 GLY MSE ALA PRO VAL GLU LYS GLU MODRES 3CGX MSE A 1 MET SELENOMETHIONINE MODRES 3CGX MSE A 33 MET SELENOMETHIONINE MODRES 3CGX MSE A 42 MET SELENOMETHIONINE MODRES 3CGX MSE A 77 MET SELENOMETHIONINE MODRES 3CGX MSE A 90 MET SELENOMETHIONINE MODRES 3CGX MSE A 94 MET SELENOMETHIONINE MODRES 3CGX MSE A 108 MET SELENOMETHIONINE MODRES 3CGX MSE A 175 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 33 8 HET MSE A 42 8 HET MSE A 77 8 HET MSE A 90 8 HET MSE A 94 8 HET MSE A 108 8 HET MSE A 175 8 HET IMD A 242 5 HETNAM MSE SELENOMETHIONINE HETNAM IMD IMIDAZOLE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 2 IMD C3 H5 N2 1+ FORMUL 3 HOH *199(H2 O) HELIX 1 1 LYS A 19 GLY A 27 1 9 HELIX 2 2 GLY A 27 ALA A 47 1 21 HELIX 3 3 ASP A 63 GLY A 73 1 11 HELIX 4 4 ASP A 85 ASP A 100 1 16 HELIX 5 5 PRO A 116 LEU A 127 1 12 HELIX 6 6 ASP A 150 PHE A 152 5 3 HELIX 7 7 CYS A 153 ASP A 158 5 6 HELIX 8 8 VAL A 167 ALA A 178 1 12 HELIX 9 9 THR A 193 ASN A 204 1 12 HELIX 10 10 SER A 207 ARG A 211 5 5 HELIX 11 11 SER A 212 ASN A 221 1 10 HELIX 12 12 ASN A 221 ARG A 226 1 6 SHEET 1 A 7 MSE A 77 ALA A 80 0 SHEET 2 A 7 ASP A 52 TYR A 57 1 N ILE A 55 O MSE A 77 SHEET 3 A 7 SER A 4 VAL A 10 1 N ILE A 6 O ASP A 52 SHEET 4 A 7 ARG A 104 MSE A 108 1 O VAL A 106 N LEU A 7 SHEET 5 A 7 TYR A 142 ARG A 148 -1 O ILE A 145 N LEU A 107 SHEET 6 A 7 ALA A 132 PRO A 136 -1 N ALA A 133 O GLY A 146 SHEET 7 A 7 VAL A 182 GLN A 184 1 O LEU A 183 N ALA A 132 LINK C MSE A 1 N SER A 2 1555 1555 1.32 LINK C ALA A 32 N MSE A 33 1555 1555 1.33 LINK C MSE A 33 N LEU A 34 1555 1555 1.33 LINK C ASP A 41 N MSE A 42 1555 1555 1.34 LINK C MSE A 42 N LEU A 43 1555 1555 1.32 LINK C HIS A 76 N MSE A 77 1555 1555 1.33 LINK C MSE A 77 N PHE A 78 1555 1555 1.33 LINK C ARG A 89 N MSE A 90 1555 1555 1.33 LINK C MSE A 90 N LYS A 91 1555 1555 1.32 LINK C ALA A 93 N MSE A 94 1555 1555 1.32 LINK C MSE A 94 N GLN A 95 1555 1555 1.33 LINK C LEU A 107 N MSE A 108 1555 1555 1.32 LINK C MSE A 108 N GLY A 109 1555 1555 1.32 LINK C LYS A 174 N MSE A 175 1555 1555 1.34 LINK C MSE A 175 N ARG A 176 1555 1555 1.33 SITE 1 AC1 5 LYS A 19 TYR A 35 ASP A 111 HOH A 262 SITE 2 AC1 5 HOH A 286 CRYST1 56.520 66.940 71.670 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017693 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014939 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013953 0.00000 HETATM 1 N MSE A 1 10.569 46.016 0.522 1.00 47.06 N HETATM 2 CA MSE A 1 11.507 44.915 0.873 1.00 46.08 C HETATM 3 C MSE A 1 10.995 44.094 2.056 1.00 43.52 C HETATM 4 O MSE A 1 10.216 44.549 2.901 1.00 40.52 O HETATM 5 CB MSE A 1 12.927 45.458 1.137 1.00 47.92 C HETATM 6 CG MSE A 1 13.182 46.048 2.500 1.00 51.23 C HETATM 7 SE MSE A 1 15.068 46.633 2.708 0.75 55.97 SE HETATM 8 CE MSE A 1 15.204 46.183 4.602 1.00 51.90 C